AF
SRNE

Allworth Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Allworth Financial’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-505
Closed -$447 – 3341
2022
Q4 		$447 Sell
505
-1,875
-79% -$2.49K ﹤0.01% 2663
2022
Q3 		$4K Buy
+2,380
New +$5.4K ﹤0.01% 1994
2022
Q2 		– Sell
-1,000
Closed -$2K – 2956
2022
Q1 		$2K Hold
1,000
– – ﹤0.01% 1854
2021
Q4 		$5K Sell
1,000
-100
-9% -$621 ﹤0.01% 1576
2021
Q3 		$8K Buy
1,100
+1,000
+1,000% +$8.48K ﹤0.01% 1421
2021
Q2 		$1K Hold
100
– – ﹤0.01% 1519
2021
Q1 		$1K Hold
100
– – ﹤0.01% 1455
2020
Q4 		$1K Buy
+100
New +$803 ﹤0.01% 1317

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Allworth Financial's SRNE Position: Q1 2023 in Review

Allworth Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 505 shares — an estimated $447 sold.

Allworth Financial first reported a position in SRNE in Q4 2020 and held it in 8 quarters. The position peaked at $8K in Q3 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Allworth Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Allworth Financial sold 505 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $447.
  • Allworth Financial first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 8 quarters.
  • Allworth Financial's Sorrento Therapeutics, Inc. position peaked at $8K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Allworth Financial's 13F filing for Q1 2023, filed 18 Apr 2023.